Mualliflar

  • Alisherova M.A., Abdujalilova M.A., Khamidullayeva M.T.

##semicolon##

invasive ductal carcinoma, early diagnosis, contrast-enhanced mammography (CEM), digital breast tomosynthesis (DBT), artificial intelligence (AI), oncological screening, imaging methods, oncology in Uzbekistan

##submission.citations##

1. AI-Based Screening Method for Early Identification of Invasive Ductal Carcinoma in Breast Cancer. 2024. https://aeis.bilijipub.com/article_199133_30ceaae22cbc519afb269ab92382b3a3.pdf

2. Ali, A., Alghamdi, M., Marzuki, S., Din, T. a. T., Yamin, M. S., Alrashidi, M., Alkhazi, I., & Ahmed, N. (2025e). Exploring AI Approaches for breast cancer detection and diagnosis: a review article. Breast Cancer Targets and Therapy, Volume 17, 927–947. https://doi.org/10.2147/ bctt.s550307

3. Alotaibi, S. A., Gareeballah, A., Rahman, J. S. U., Faqihi, W. A., Ali, S., Elbashir, M., Haj, N., Abdulrhman, K. M. S., Ahmed, R. a. A., Hazazi, A., & Ali, B. (2025). Evaluation of the diagnostic accuracy of mammography and ultrasonography for breast cancer diagnosis using histopathology as the reference standard: a cross-sectional study. Annals of Medicine and Surgery, 88(1), 159–166. https://doi.org/10.1097/ms9.0000000000004369

4. Anampa, J. D., Lin, S., Obeng-Gyasi, S., & Xue, X. (2024). Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast. Cancer Epidemiology Biomarkers & Prevention, 34(1), 125–132. https://doi.org/ 10.1158/1055-9965.epi-24-1250

5. Bikayev, Yu. V., Shamilova, M. A., Sencha, A. N., Gaylish, Yu. P., Oshkina, E. V., Khiyeva, V. A., Zaytsev, N. A., & Abakarov, Ya. M. (2024). Mikropapillyarnaya kartsinoma molochnoy zhelezy: ot molekulyarnykh kharakteristik do prognoza [Micropapillary carcinoma of the breast: from molecular characteristics to prognosis]. Meditsinskiy opponent, (4).URL: https://cyberleninka.ru/ article/n/mikropapillyarnaya-kartsinoma-molochnoy-zhelezy-ot-molekulyarnyh-harakteristik-do-prognoza (дата обращения: 22.03.2026).

6. Budi Susilo, Yudi Kurniawan and Abdul Rahman, Shamima and Abdul Rasyid, Faradiba and Yuliana, Dewi (2025) Artificial Intelligence in cancer screening: a bibliometric analysis of advances in early detection accuracy/ Yudi Kurniawan Budi Susilo... [et al.]. Journal of Information and Knowledge Management (JIKM), 15 (1). pp. 30-45. https://ir.uitm.edu.my/id/eprint/113425/1/ 113425.pdf

7. Cakmak, Y., & Pacal, I. (2025). Enhancing Breast Cancer Diagnosis: A Comparative Evaluation of Machine Learning Algorithms Using the Wisconsin Dataset. Journal of Operations Intelligence, 3(1), 180-201. https://doi.org/10.31181/jopi31202539

8. Çetin, İ. A., & Bekiroğlu, N. (2025). A bibliometric analysis of uzbekistan publications in the field of oncology based on web of science data in 2019-2024. Central Asian Journal of Medical Hypotheses and Ethics, 6(1), 63–70. https://doi.org/10.47316/cajmhe.2025.6.1.07

9. Chen, J., Pan, T., Zhu, Z. et al. A deep learning-based multimodal medical imaging model for breast cancer screening. Sci Rep 15, 14696 (2025). https://doi.org/10.1038/s41598-025-99535-2

10. Dr. Abiramasundari V Ket al. (2024), Assessing The Efficacy: A Comparative Analysis Of Invasive And Non-Invasive Diagnostic Methods For Early Detection And Screening Of Breast Cancer Educational Administration: Theory And Practice, 30(4), 3610-3617, https://doi.org/ 10.53555/kuey.v30i4.2093

11. Fedai, N., Koc, I., Kavgaci, G., Uner, M., Uner, A., Aksoy, S., & Kertmen, N. (2025). Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes. Molecular and Clinical Oncology, 24(1), 1–8. https://doi.org/10.3892/mco.2025.2910

12. Freihat, O., Sipos, D., & Kovacs, A. (2025). Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data. Frontiers in Public Health, 13, 1622954. https://doi.org/10.3389/fpubh.2025.1622954

13. Fu, M., Peng, Z., Wu, M., Lv, D., Li, Y., & Lyu, S. (2024). Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050. The Breast, 79, 103835. https://doi.org/10.1016/j.breast.2024.103835

14. Futamura, M., Nagao, Y., Takai, Y. et al. Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer. Breast Cancer 33, 72–79 (2026). https://doi.org/10.1007/s12282-025-01775-7

15. Gennaro, G., Baldan, E., Bednarova, I., Belli, P., Bernardi, D., Bezzon, E., Ciriello, G., Coran, A., Iotti, V., Polico, I., Zovato, S., & Caumo, F. (2026). Clinical performance of Contrast-Enhanced Mammography versus breast MRI in women at increased breast cancer risk. Cancers, 18(5), 759. https://doi.org/10.3390/cancers18050759

16. Global Cancer Observatory: Uzbekistan Fact Sheet. (n.d.).https://gco.iarc.who.int/media/ globocan/factsheets/populations/860-uzbekistan-fact-sheet.pdf?hl=en-US

17. Hamad, W., Michell, M. J., Myles, J. P., Gilbert, F. J., Chen, Y., Jin, H., Loveland, J., Halling‐Brown, M., Satchithananda, K., Morel, J., Wasan, R., Taylor, C., Sharma, N., Valencia, A., Teh, W., Majid, F., De Visser, R. M., Iqbal, A., & Duffy, S. W. (2024). Diagnostic performance of tomosynthesis plus synthetic mammography versus full‐field digital mammography with or without tomosynthesis in breast cancer screening: A systematic review and meta‐analysis. International Journal of Cancer, 156(5), 969–979. https://doi.org/10.1002/ijc.35217

18. Intriago-Baldeón, D. P., Pérez-Coral, E. S., Samaniego, M. I. A., Romero, V. I., Palacios, J. C. P., & Bigoni-Ordóñez, G. D. (2025). Decoding Breast Cancer: Emerging molecular biomarkers and novel therapeutic targets for precision medicine. International Journal of Molecular Sciences, 27(1), 138. https://doi.org/10.3390/ijms27010138

19. Jelski, W., Okrasinska, S., & Mroczko, B. (2025). MicroRNAs as biomarkers of breast cancer. International Journal of Molecular Sciences, 26(9), 4395. https://doi.org/10.3390/ ijms26094395

20. Kazemi, S. A., Konstantin, K., Masal, M. N., & Ishaq, A. (2025). The role of circulating tumor DNA in early detection of HER2-positive breast cancer. Journal of Cancer and Tumor International, 15(2), 64–78. https://doi.org/10.9734/jcti/2025/v15i2293

21. Khan, A. Q., Touseeq, M., Rehman, S., Tahir, M., Ashfaq, M., Jaffar, E., & Abbasi, S. F. (2025). Advances in breast cancer diagnosis: a comprehensive review of imaging, biosensors, and emerging wearable technologies. Frontiers in Oncology, 15, 1587517. https://doi.org/10.3389/ fonc.2025.1587517

22. Kim, J. S., Lee, J. H., Yeon, Y., An, D., Kim, S. J., Noh, M., & Lee, S. (2025). Predicting Nottingham grade in breast cancer digital pathology using a foundation model. Breast Cancer Research, 27(1), 58. https://doi.org/10.1186/s13058-025-02019-4

23. Lu, Y., Ren, L., Yang, M., & Liu, J. (2025). Clinical Management of Circulating Tumor DNA in Breast Cancer: Detection, Prediction, and Monitoring. Breast Cancer: Targets and Therapy, 17, 851–861. https://doi.org/10.2147/BCTT.S542704

24. Mathur, P., Dhanekar, S., & Malhotra, B. D. (2025b). A review on breast cancer diagnostic techniques. Sensors & Diagnostics, 4(7), 555–573. https://doi.org/10.1039/d5sd00016e

25. Neubauer, C., Nattenmüller, J., Bamberg, F., Windfuhr-Blum, M., & Neubauer, J. (2025). Breast cancer assessment under neoadjuvant systemic therapy using thoracic photon-counting detector computed tomography in prone position: a pilot study. European Radiology Experimental, 9(1), 41. https://doi.org/10.1186/s41747-025-00576-z

26. Rahman MA, Khan MSH, Watanobe Y, Prioty JT, Annita TT, Rahman S, Hossain MS, Aitijjo SA, Taskin RI, Dhrubo V, et al. Advancements in Breast Cancer Detection: A Review of Global Trends, Risk Factors, Imaging Modalities, Machine Learning, and Deep Learning Approaches. BioMedInformatics. 2025; 5(3):46. https://doi.org/10.3390/biomedinformatics5030046

27. Rim, C. H., Lee, W. J., Musaev, B., Volichevich, T. Y., Pazlitdinovich, Z. Y., Lee, H. Y., Nigmatovich, T. M., & Rim, J. S. (2022). Comparison of breast cancer and cervical cancer in Uzbekistan and Korea: The first report of the Uzbekistan–Korea Oncology Consortium. Medicina, 58(10), 1428. https://doi.org/10.3390/medicina58101428

28. Sabeti, S., Parvar, T. A., Metanat, P., Larson, N. B., Fazzio, R. T., Fatemi, M., & Alizad, A. (2025). Quantitative angiogenesis-based ultrasound biomarkers for differentiating radiologically challenging breast lesions: Radial scar vs invasive ductal carcinoma. The Breast, 84, 104614. https://doi.org/10.1016/j.breast.2025.104614

29. Sh.J. Jovliyev, & S.A. Musurmonova. (2025). Sut bezi saratoni: erta aniqlash va skriningning ahamiyati. Universal Science Research Jurnali, 3(6 (SPECIAL ISSUE), 7–8. https://inlibrary.uz/index.php/universal-scientific-research/article/view/114278

30. Shi, Z., Qiu, P., Wang, Y., & Liu, H. (2025). Minimally invasive biopsy technique predicting breast pathological complete response after neoadjuvant therapy for breast cancer. Gland Surgery, 14(7), 1263–1271. https://doi.org/10.21037/gs-2025-103

31. Shirzad, M., Shaban, M., Mohammadzadeh, V., Rahdar, A., Fathi-Karkan, S., Hoseini, Z. S., Najafi, M., Kharaba, Z., & Aboudzadeh, M. A. (2025). Artificial Intelligence-Assisted Design of Nanomedicines for Breast cancer diagnosis and therapy: Advances, challenges, and future directions. BioNanoScience, 15(3). https://doi.org/10.1007/s12668-025-01980-w

32. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022c). Cancer statistics, 2022. CA a Cancer Journal for Clinicians, 72(1), 7–33. https://doi.org/10.3322/caac.21708

33. Singh, G. N., Shahi, N., Suryavanshi, P., Singh, K. K., & Nigam, N. (2025). Role of micro RNA expression as biomarker in breast cancer. Annals of African Medicine, 24(3), 549–554. https://doi.org/10.4103/aam.aam_78_23

34. Srikanth, M.., Dwivedi, K.., Koli, V.., Sejpal, J.., Shrishail, K.., Rajendra, R.., & Bose, S.. (2025). Breast cancer diagnosis: a comparative study of methods based on sensitivity and specificity. International Journal of Medical Sciences, 1(3), 39–43. https://inlibrary.uz/index.php/ijms/article/ view/80004

35. Tillyashaykhov, M., Djanklich, S., Ososkov, A., Sabirdjanova, Z., Ibragimov, S., & Isanbayeva, A. (2025). Breast cancer morbidity and role of mammographic screening program in Uzbekistan. Journal of Clinical Oncology, 43(16_suppl). https://doi.org/10.1200/jco.2025.43. 16_suppl.e22510

36. View of Grading Invasive Ductal Carcinoma from Whole-Slide Histological Images using Deep Learning-Based Feature Encoding Techniques. (n.d.). https://ph02.tci-thaijo.org/index.php/ mijet/article/view/257747/173351

37. Wang, J., Li, B., Luo, M., Huang, J., Zhang, K., Zheng, S., Zhang, S., & Zhou, J. (2024). Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance. Signal Transduction and Targeted Therapy, 9(1), 83. https://doi.org/10.1038/s41392-024-01779-3

38. Wang, Z., Bai, C., Zhang, N., Han, Z., Dong, H., Liu, S., Meng, J., & Zhang, C. (2026). Predicting histological grade in invasive ductal carcinoma of the breast: a radiomics-based machine learning model using DCE-MRI. Frontiers in Oncology, 15, 1593075. https://doi.org/10.3389/ fonc.2025.1593075

39. Yoon KH, Ahn JH, Kim JY, Park HS, Kim SI, Park S. Impact of Axillary Burden on Survival: A Comparative Study of Invasive Lobular Carcinoma and Invasive Ductal Carcinoma in Early-Stage Breast Cancer. Cancers. 2025; 17(6):1002. https://doi.org/10.3390/cancers17061002

Zhang, X., Yin, Y., Ye, Z., Zhang, X., Wei, W., Hao, Y., Zeng, L., Yang, T., Li, D., Wang, J., Zhao, D., Chen, Y., Lei, S., Jiang, Y., Zhang, Y., Xu, S., Nanding, A., Gong, Y., Li, S.,... Pang, D. (2025). An approach for differential diagnosis of breast tumors by CTDNA methylation sequencing. Cancer Medicine, 14(12), e71004. https://doi.org/10.1002/cam4.71004